Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Learn how backpropagation works by building it from scratch in Python! This tutorial explains the math, logic, and coding behind training a neural network, helping you truly understand how deep ...

Learn how gradient descent really works by building it step by step in Python. No libraries, no shortcuts—just pure math and code made simple.

Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...

Welcome to the Python Learning Roadmap in 30 Days! This project is designed to guide you through a structured 30-day journey to learn the Python programming language from scratch and master its ...